VR-23(VR23)|Proteasome Inhibitor|From DC Chemicals

VR-23(VR23)|Proteasome Inhibitor|From DC Chemicals

VR-23 is a Quinoline-Sulfonyl Hybrid Proteasome Inhibitor That Selectively Kills Cancer via Cyclin E–Mediated Centrosome Amplification

Product Name: VR23 |Catalog Number: DC8448 |CAS 1624602-30-7 |Other names: VR-23,VR 23 |Chemical Name:  |Molecule Formular: C19H16ClN5O6S |MW: 477.88

VR23, shows strong potential as a next generation proteasome inhibitor, inhibiting tumor growth as a single agent.  Furthermore, when used in combination with gold-standard anticancer drugs, VR23 can increase efficacy while reducing toxicity. VR23 also shows significant potential in overcoming drug resistance. For the detailed information of VR23, the solubility of VR23 in water, the solubility of VR23 in DMSO, the solubility of VR23 in PBS buffer, the animal experiment (test) of  VR23, the cell expriment (test) of VR23, the in vivo, in vitro and clinical trial test of VR23, the EC50, IC50,and affinity,of VR23, For the detailed information of VR23, the solubility of VR23 in water, the solubility of VR23 in DMSO, the solubility of VR23 in PBS buffer, the animal experiment (test) of  VR23, the cell expriment (test) of VR23, the in vivo, in vitro and clinical trial test of VR23, the EC50, IC50,and affinity,of VR23, Please contact DC Chemicals.

For research and scientific purpose only, not for human use.